Faculty, Staff and Student Publications
Open-access journal articles from UTHealth GSBS faculty, staff and students.
Submissions from 2025
A Pioneering Artificial Intelligence Tool To Predict Treatment Outcomes in Ovarian Cancer via Diagnostic Laparoscopy, Xiaotian Ma, Yu-Chun Hsu, Amma Asare, et al.
Alpha-Frequency Stimulation Strengthens Coupling Between Temporal Fluctuations in Alpha Oscillation Power and Default Mode Network Connectivity, Yijia Ma, Joshua A Brown, Chaowen Chen, et al.
An Allele-Agnostic Mutant-Kras Inhibitor Suppresses Tumor Maintenance Signals and Reprograms Tumor Immunity in Pancreatic Cancer, Kathleen M McAndrews, Francesca Paradiso, Clint A Stalnecker, et al.
A Method for Sensitivity Analysis of Automatic Contouring Algorithms Across Different Contrast Weightings Using Synthetic Magnetic Resonance Imaging, Lucas McCullum, Zayne Belal, Warren Floyd, et al.
Technical Development and In Silico Implementation of SyntheticMR in Head and Neck Adaptive Radiation Therapy: A Prospective R-Ideal Stage 0/1 Technology Development Report, Lucas McCullum, Samuel L Mulder, Natalie A West, et al.
Utility of the US Preventive Services Task Force for Preeclampsia Risk Assessment and Aspirin Prophylaxis, Thomas F McElrath, Arun Jeyabalan, Arkady Khodursky, et al.
Biomarkers for the Diagnosis of Indeterminate Pulmonary Nodules: Are We There Yet?, Kevin C McGann, Timothy A Khalil, Michael N Kammer, et al.
Predicting Sinonasal Inverted Papilloma Attachment Using Machine Learning: Current Lessons and Future Directions, Sean P McKee, Xiaomin Liang, William C Yao, et al.
Neutrophils Unveiled in Chronic Lymphocytic Leukemia, Sheighlah McManus, Priyanka Khare, and Maria Teresa S Bertilaccio
Manual Therapy for Fibrosis-Related Late Effect Dysphagia in Head and Neck Cancer Survivors: The MANTLE Nonrandomized Clinical Trial, Holly McMillan, Carla L Warneke, Sheila Buoy, et al.
Community Outreach, Engagement, and Mentoring Program for Underrepresented Scholars in Cancer Health Disparities, Lorna H McNeill, Cassandra L Harris, Terrence R Adams, et al.
Visualization of Lysosomal Membrane Proteins by Cryo Electron Tomography, Bridget M McVeigh, José J De Jesús-Pérez, Dirk H Siepe, et al.
Polydrug Abuse: Choice Between Drugs as a Function of Concurrent Nonindependent Ratio Sizes, Richard A Meisch, Thomas H Gomez, and Scott D Lane
Additional Evidence From a Case Report Supports a Novel Hypothesis on the Association Between Complex Regional Pain Syndrome and Lymphedema, M Mark Melin, John C Rasmussen, Melissa B Aldrich, et al.
Overcoming CD226-Related Immune Evasion in Acute Myeloid Leukemia With CD38 CAR-Engineered NK Cells, Luciana Melo Garcia, Achintyan Gangadharan, Pinaki Banerjee, et al.
Histone Methyltransferase ASH1L Primes Metastases and Metabolic Reprogramming of Macrophages in the Bone Niche, Chenling Meng, Kevin Lin, Wei Shi, et al.
Epigenetic Age Acceleration Mediates Treatment Effects on Cardiometabolic and Cardiovascular Risk in Childhood Cancer Survivors, Xiaoxi Meng, Tiffany Eulalio, Yoonji Kim, et al.
POLARIS: Encorafenib Plus Binimetinib for People With BRAF V600-Mutant Melanoma With Brain Metastasis, Alexander M Menzies and Michael A Davies
A Plain Language Summary of POLARIS: A Study To Look at Different Doses of Encorafenib Plus Binimetinib for People With BRAF V600-Mutant Melanoma With Brain Metastasis, Alexander M Menzies, Georgina V Long, Amiee Kohn, et al.
Prophylaxis, Clinical Management, and Monitoring of Datopotamab Deruxtecan-Associated Oral Mucositis/Stomatitis, Funda Meric-Bernstam, Aditya Bardia, Paolo Bossi, et al.
Phase 2 Study of Zilovertamab Vedotin in Participants With Metastatic Solid Tumors, Funda Meric-Bernstam, Martin Gutierrez, Enrique Sanz-Garcia, et al.
Plain Language Summary: An Analysis of the Safety of Futibatinib Treatment in People With Different Types of Cancer, Funda Meric-Bernstam, Antoine Hollebecque, Junji Furuse, et al.
ctDNA Analysis in ERBB2-Amplified Colorectal Cancer: Biomarker Analysis of the MyPathway Trial, Funda Meric-Bernstam, Kanwal Pratap Singh Raghav, Christopher J Sweeney, et al.
Zanidatamab Monotherapy or Combined With Chemotherapy in HER2-Expressing Gastroesophageal Adenocarcinoma: A Phase 1 Trial, Funda Meric-Bernstam, Sun Young Rha, Erika Hamilton, et al.
Antitumor Activity and Biomarker Analysis for TROP2 Antibody-Drug Conjugate Datopotamab Deruxtecan in Patient-Derived Breast Cancer Xenograft Models, Funda Meric-Bernstam, Erkan Yuca, Kurt W Evans, et al.